Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity-Reference-Cited by-同舟云学术

Retinoprotective Effect of SkQ1, Visomitin Eye Drops, Is Associated with Suppression of P38 MAPK and ERK1/2 Signaling Pathways Activity

Published:2024-02 Issue:2 Volume:89 Page:201-211
ISSN:0006-2979
Container-title:Biochemistry (Moscow)
language:en
Short-container-title:Biochemistry Moscow

Author:

Muraleva Natalia A.,Zhdankina Anna A.,Fursova Anzhella Zh.,Kolosova Nataliya G.

Publisher

Pleiades Publishing Ltd

Link

https://link.springer.com/content/pdf/10.1134/S0006297924020020.pdf

Reference39 articles.

1. Skulachev, V. P. (2007) A biochemical approach to the problem of aging: “megaproject” on membrane-penetrating ions. The first results and prospects, Biochemistry (Moscow), 72, 1385-1396, https://doi.org/10.1134/s0006297907120139.

2. Zhdankina, A. A., Fursova, A., Logvinov, S. V., and Kolosova, N. G. (2008) Clinical and morphological characteristics of chorioretinal degeneration in early aging OXYS rats, Bull. Exp. Biol. Med., 146, 455-458, https://doi.org/10.1007/s10517-009-0298-4.

3. Kozhevnikova, O. S., Korbolina, E. E., Stefanova, N. A., Muraleva, N. A., Orlov, Y. L., and Kolosova, N. G. (2013) Association of AMD-like retinopathy development with an Alzheimer’s disease metabolic pathway in OXYS rats, Biogerontology, 14, 753-762, https://doi.org/10.1007/s10522-013-9439-2.

4. Neroev, V. V., Archipova, M. M., Bakeeva, L. E., Fursova, A., Grigorian, E. N., Grishanova, A. Y., Iomdina, E. N., Ivashchenko, Zh. N., Katargina, L. A., Khoroshilova-Maslova, I. P., Kilina, O. V., Kolosova, N. G., Kopenkin, E. P., Korshunov, S. S., Kovaleva, N. A., Novikova, Y. P., Philippov, P. P., Pilipenko, D. I., Robustova, O. V., Saprunova, V. B., and Skulachev, V. P. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals, Biochemistry (Moscow), 73, 1317-1328, https://doi.org/10.1134/s0006297908120043.

5. Erichev, V. P., Kozlova, I. V., Reshchikova, V. S., Alekseev, V. N., Levko, M. A., Zamyatin, A. A., Gudkova, E. Yu., Koveleva, N. A., Vygodin, V. A., Fedorkin, O. N., Ostapenko, V., Senin, I. I., Savchenko, A. Yu., Popeko, N. A., Skulachev, V. P., and Skulachev, M. V. (2016) Clinical trial examining efficiency and safety of the Visomitin® eye drops in the patients with age-related cataract, Natl Zh. Glaukoma, 15, 61-69.